Ian David Wall

USPTO Granted Patents = 13 (Patent Applications = 2)

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 8 (Patent Applications = 10)

Average Co-Inventor Count = 9.3

ph-index = 2

Forward Citations = 25(Granted Patents)

Location History:

Harlow, GB (2012)
Stevenage, GB (2013 - 2022)

Company Filing History:

11 out of 92

Glaxosmithkline Intellectual Property (no.2) Limited

Years Active: 2012-2022

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11319307 - 2,3-dihydrobenzohurans as bromodomain inhibitors (2022-05-03),

2. 11273146 - Benzofuran derivatives and their use as bromodomain inhibitors (2022-03-15),

3. 10966961 - Pyrazole derivatives as bromodomain inhibitors (2021-04-06),

4. 10934272 - Pyridyl derivatives as bromodomain inhibitors (2021-03-02),

5. 10927080 - Pyridinone dicarboxamide for use as bromodomain inhibitors (2021-02-23),

6. 10849897 - Pyridyl derivatives as bromodomain inhibitors (2020-12-01),

7. 10844015 - Pyridine dicarboxamide derivatives as bromodomain inhibitors (2020-11-24),

8. 10583112 - Benzo[b]furans as bromodomain inhibitors (2020-03-10),

9. 10471050 - 2-OXO-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitors (2019-11-12),

10. 10428026 - Pyridinone dicarboxamide for use as bromodomain inhibitors (2019-10-01),

11. 10370356 - Pyridinone dicarboxamide for use as bromodomain inhibitors (2019-08-06),

12. 8513248 - 5,6,7,8-tetrahydroimidazo[1,2-A]pyrazine derivatives as P2X7 modulators (2013-08-20),

13. 8222245 - Oxadiazole derivatives active on sphingosine-1-phosphate (S1P) (2012-07-17),

Title: Inventor Spotlight: Ian David Wall

Introduction

Ian David Wall, an accomplished inventor based in Stevenage, Great Britain, has made significant contributions to the field of pharmaceuticals with his innovative designs and applications. With a total of 13 patents to his name, Wall continues to push the boundaries of therapeutic developments.

Latest Patents

Among his latest patents are the following groundbreaking inventions:

1. **2,3-dihydrobenzohurans as bromodomain inhibitors** - This invention relates to compounds of formula (I) and salts thereof, along with pharmaceutical compositions that incorporate these compounds and their application in therapy.

2. **Benzofuran derivatives and their use as bromodomain inhibitors** - Similar to his previous patent, this invention addresses compounds of formula (I) and their therapeutic usage, providing new avenues for medical treatments.

Career Highlights

Throughout his career, Ian Wall has worked with notable organizations, including GlaxoSmithKline Intellectual Property Limited and Glaxo Group Limited. His work in these companies has exemplified his commitment to advancing pharmaceutical research and innovation.

Collaborations

Wall's journey has seen him collaborate with esteemed colleagues such as Emmanuel Hubert Demont and Stephen John Atkinson. These collaborations have undoubtedly enriched his research and contributed to the impactful inventions he has developed.

Conclusion

Ian David Wall remains a prominent figure in the realm of pharmaceuticals, with a robust portfolio of patents that reflect his dedication to improving therapeutic options. Through his innovative spirit and collaborative efforts, he continues to pave the way for future advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.